Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08IST
|
|||
| Former ID |
DND000043
|
|||
| Drug Name |
SB-509
|
|||
| Synonyms |
ALS therapy, Sangamo; Diabetic neuropathy therapy, Sangamo; AdV-ZFP-VEGF; VEGF ZFP TF, Sangamo-2; VEGF activation, Sangamo-2
Click to Show/Hide
|
|||
| Indication | Nervous system disease [ICD-11: 8A00-8E7Z; ICD-10: G64, G90.0] | Phase 2 | [1] | |
| Company |
Sangamo BioSciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01079325) Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.